Study of CM512 Injection in Subjects With Chronic Spontaneous Urticaria(CSU) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Study of CM512 Injection in Subjects With Chronic Spontaneous Urticaria(CSU) — Stella

Recruiting

Back to Chronic Spontaneous Urticaria (CSU) trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

China

Tianjin Academy of Traditional Chinese Medicine Affiliate Hospital, Tianjin, Tianjin Municipality

Key details

Phase

Safety & dosing

Sponsor

Keymed Biosciences Co.Ltd

Enrollment target

~48 participants

Started

November 2025

Primary completion

November 2026

Age range

18 Years – 75 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov